Trials / Completed
CompletedNCT00972439
Oral Contraceptive (OC) Progestin Dose and Breast Proliferation
Evaluating the Effect of Oral Contraceptive Progestin Dose on Breast Epithelial Cell Proliferation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- University of Southern California · Academic / Other
- Sex
- Female
- Age
- 18 Years – 34 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this research study is to gain a better understanding of the changes that may occur in the breast when a woman uses an oral contraceptive (birth control pill). Some research indicates that women who use birth control pills with lower amounts of progestin (a hormone in the birth control pill) may have lower breast cell growth than women who use birth control pills with a higher amount of progestin; this research will examine that in detail.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oral Contraceptive: Ortho-Novum® 1/35 | |
| DRUG | Oral Contraceptive: Ovcon Fe® |
Timeline
- Start date
- 2007-08-01
- Primary completion
- 2008-11-01
- Completion
- 2008-11-01
- First posted
- 2009-09-07
- Last updated
- 2018-02-23
- Results posted
- 2018-02-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00972439. Inclusion in this directory is not an endorsement.